EPISODE · Jun 14, 2022 · 11 MIN
WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC
from Answers from the Lab · host Mayo Clinic Laboratories
(00:32):Before we jump in, would each of you share a little bit about your background and yourselves? (01:18):Dr. Marcou. could you provide us with an overview of what the WESDX test is? (01:50):Marissa, would you help explain why this test is important? (03:10):In your experience who would benefit from WESDX,(05:12):How does a provider order A WES DX and secondarily what type of samples are accepted?(06:24):What types of variants are detected by the test? (07:47):There are a lot of exome tests available. What are some other unique features that set WESDX apart? (09:52):Last question, could you summarize the benefits of doing WESDX at Mayo?
Embed this episode
What this episode covers
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. This comprehensive, next-generation sequencing evaluation investigates approximately 20,000 genes for variations associated with genetic disease. Recommended by the American College of Medical Genetics and Genomics as a first-line test for individuals with one or more congenital abnormalities, WES enables individualized insights on genetic variants that can facilitate diagnosis, prognosis, and management decisions.
NOW PLAYING
WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.